Wikidata

(Q39966289)

English

Combination of rapamycin and 17-allylamino-17-demethoxygeldanamycin abrogates Akt activation and potentiates mTOR blockade in breast cancer cells

scientific article

In more languages

Statements

title
Combination of rapamycin and 17-allylamino-17-demethoxygeldanamycin abrogates Akt activation and potentiates mTOR blockade in breast cancer cells (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
18594209
retrieved
16 September 2017
author name string
Matthew M Roforth
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
18594209
retrieved
16 September 2017
Chalet Tan
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
18594209
retrieved
16 September 2017
publication date
1 August 2008
1 reference
stated in
Europe PubMed Central
PubMed ID
18594209
retrieved
16 September 2017
page(s)
681-688
1 reference
stated in
Europe PubMed Central
PubMed ID
18594209
retrieved
16 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39966289&oldid=1881445376"